Literature DB >> 3956330

Dopamine-induced migrating myoelectrical complex-like activity in human duodenum.

L Marzio, M Neri, A M Di Giammarco, F Cuccurullo, G A Lanfranchi.   

Abstract

The effect of dopamine on human gastric and small intestinal interdigestive motility was investigated in 12 subjects. Intestinal motility was recorded by means of a four-lumen polyvinyl probe with four open tips located 15 cm apart, continuously perfused with distilled water. In each subject during the same study, after recording two consecutive spontaneous phase III of migrating myoelectrical complexes and when a phase II appeared, dopamine was infused intravenously twice in a dose of 5 micrograms/kg/min for 15 min with an interval of 20 min between each infusion. In six subjects, the second dopamine infusion was preceded by a treatment with sulpiride (10 mg, intravenously, as bolus) or domperidone (10 mg, intravenously, as bolus), each considered a highly selective dopamine antagonist. The results show that dopamine stimulates duodenal motility producing a pattern similar to that observed in phase III of spontaneously occurring migrating myoelectrical complexes. The second dopamine infusion reproduced in all cases the same pattern of motility as observed during the first infusion. Sulpiride and domperidone prevented the effect of dopamine in all cases. It is therefore suggested that dopamine-induced duodenal motility may involve specific dopaminergic receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956330     DOI: 10.1007/bf01311668

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

Review 1.  Metoclopramide.

Authors:  K Schulze-Delrieu
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

Review 2.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

Review 3.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

4.  Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidone.

Authors:  J M Van Nueten; C Ennis; L Helsen; P M Laduron; P A Janssen
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

5.  Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

Authors:  P M Laduron; J E Leysen
Journal:  Biochem Pharmacol       Date:  1979-07-15       Impact factor: 5.858

6.  The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.

Authors:  G Vantrappen; J Janssens; J Hellemans; Y Ghoos
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

7.  Effect of dopamine on opossum duodenal smooth muscle.

Authors:  S Anuras
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

8.  Electrical patterns in the human jejunum with and without vagotomy: migrating myoelectrical complexes and the influence of morphine.

Authors:  W E Waterfall
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

9.  Effect of dopamine on esophageal motor function.

Authors:  A K Mukhopadhyay; N Weisbrodt
Journal:  Am J Physiol       Date:  1977-01

10.  Motor effect of dopamine on human sigmoid colon. Evidence for specific receptors.

Authors:  G A Lanfranchi; L Marzio; C Cortini; E M Osset
Journal:  Am J Dig Dis       Date:  1978-03
View more
  4 in total

Review 1.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Dopamine interrupts gastrointestinal fed motility pattern in humans. Effect on motilin and somatostatin blood levels.

Authors:  L Marzio; M Neri; O Pieramico; M Delle Donne; T L Peeters; F Cuccurullo
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

Review 3.  Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.

Authors:  Vinod Metta; Valentina Leta; Kandadai Rukmini Mrudula; L K Prashanth; Vinay Goyal; Rupam Borgohain; Guy Chung-Faye; K Ray Chaudhuri
Journal:  J Neurol       Date:  2021-04-21       Impact factor: 4.849

Review 4.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.